Tech Company Financing Transactions

Microbia PE Funding Round

On 2/27/2006, Microbia PE raised $75 million in Series E investment from Sigma Prime Ventures, F-Prime Capital and Maverick Capital.

Transaction Overview

Company Name
Announced On
2/27/2006
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series E
Proceeds Purpose
This significant infusion of equity capital will be utilized to advance our proprietary pipeline of novel therapeutics through clinical trials, including both MD-1100 and our Phase 1 cholesterol absorption inhibitor MD-0727,

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
60 Westview Street
Lexington, MA 02421
USA
Email Address
Overview
Microbia is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking.
Profile
Microbia PE LinkedIn Company Profile
Social Media
Microbia PE Company Twitter Account
Company News
Microbia PE News
Facebook
Microbia PE on Facebook
YouTube
Microbia PE on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Marcus Smith
  Marcus Smith LinkedIn Profile  Marcus Smith Twitter Account  Marcus Smith News  Marcus Smith on Facebook
Chief Scientific Officer
Kevin Madden
  Kevin Madden LinkedIn Profile  Kevin Madden Twitter Account  Kevin Madden News  Kevin Madden on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/27/2006: EGT venture capital transaction
Next: 2/27/2006: MeeVee venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary